Chargement en cours...
The Impact of Systemic Therapy Following Ductal Carcinoma In Situ
Following local therapy for ductal carcinoma in situ (DCIS), tamoxifen reduces the risk of ipsilateral and contralateral breast cancer by 30%–50%. Studies of tamoxifen in women with resected DCIS have not shown any effect on overall or cancer-specific survival. The adverse event profile of tamoxifen...
Enregistré dans:
| Publié dans: | J Natl Cancer Inst Monogr |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Oxford University Press
2010
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4999067/ https://ncbi.nlm.nih.gov/pubmed/20956830 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jncimonographs/lgq021 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|